Biography:

Rabindra Karki was involved in various projects in his country Nepal. He worked as a Project coordinator at Mission Oxygen Team (MOT), Kathmandu, Nepal in a project funded by UNDP where he coordinated different workshops at different parts of the country for training on repair and maintenance of Biomedical Equipments to Biomedical Engineers. During 2019 COVID-19 pandemic he worked as a consultant Microbiologist for the Ministry of Health and Population of Nepal to establish a laboratory for COVID-19 testing in a hospital in Nepal where he supervised sixteen staffs.

His research experience spans from Cholera study in Hospital patients in Nepal to environmental study of Pseudomonas in a lake water in Germany. He has also some research experience on Stem cells, Tissue engineering, Cancer biology , Diabetes and Autophagy. He has laboratory research experience in different countries like: Germany, Sweden, USA and China.

 

Goal:

One of his major goals in life is to improve human health by making scientific discoveries.

​

Research Interests:

- Infectious Diseases

- Molecular Biology

- Omics Science

- Host-Pathogen Interactions

- Environmental Microbiology

​

Education:

2002-2005 B.Sc. (3 yrs.) in Microbiology, Tribhuvan University, NEPAL

2005-2007 M.Sc. (2 yrs.) in Medical Microbiology (Passed with Distinction), Central Department of Microbiology, Tribhuvan University, NEPAL

2010-2011 M.Sc. (1 yr.) in Molecular biology, Department of Natural Sciences, University Of SkÖvde, SWEDEN

2012- 2014 M.Sc. (2.8 yr.) in Biochemistry, Department of Medical Microbiology, Molecular Biology, Immunology, Cell biology and Biochemistry, Southern Illinois University School Of Medicine , Springfield, Illinois, USA

​

Publications:

1. Karki R, Gupta A, Maffulli N, Albers C, Roberts M H, Iii S F E, Human anterior cruciate ligament-derived mesenchymal stem cells for regenerative medicine applications. IP Int J Orthop Rheumatol 2023;9(1):35-45

2. Munankarmi NN, Karki R. Is it time to turn back in time to treat novel COVID-19 disease? -current situation in Nepal. Precision Medicine Research. 2021;3(3):14. doi: 10.53388/PMR2021080201.

3. Walters MA., Chambers MC., Karki R., Knox E., Levengood G., El-AminSF.(2016). Anterior Cruciate Ligament Tissue Engineering: A Review of Current Investigations. JNanotech Mater Sci.3(1): 1- 7

4. Karki, R. and Kul Raj Rai (2016) Where Cholera Vaccination should be initiated in Nepal, if at all? BAOJ Aller Immunol.1: 005.

5. Karki R.(2015):Management of disease outbreak in Nepal.Lancet.386(9991):335-6. doi: 10.1016/S0140-6736(15)61403-9.

6. Karki, R., Bhatta, DR., Malla, S. and Dumre, SP. (2011): Resistotypes of Vibrio cholerae 01 Ogawa Biotype El Tor in Kathmandu, Nepal. Nepal Med Coll J. 13(2):84-7.

7. Karki, R., Bhatta, DR., Malla, S. and Dumre, SP. (2010): Cholera Incidence among Patients with Diarrhea Visiting National Public Health Laboratory, Nepal. Short communication. Jpn. J. Infect. Dis., 63 (3): 185-7.

 

In News/Media

His article was featured in the University of California Los Angeles (UCLA) during Haiti Cholera Outbreak in 2010 http://www.ph.ucla.edu/epi/snow/cholera_haiti_newdev1.html​